24 March 2014: Open Source Drug Discovery launched the Phase II B clinical trials of  the new combination drug for TB -PaMZ in collaboration with the National Institute of Tuberculosis & Respiratory Diseases, New Delhi. The proposed trial is a three arm trial examining the safety and efficacy of the said combination on multi-drug resistant tuberculosis in Indian patients. The protocols for the Phase IIB clinical trials of PaMZ was released by Dr. T Ramasami, Secretary , DST and Director General CSIR in presence of  Dr. V. M Katoch Secretary, Department of Health Research & Director General, ICMR, Dr. Jagdish Prasad, Director General of Health Services and Dr. Rohit Sarin , Director, NITRD. NITRD is the Investigator institute and Dr Rohit Sarin is the Principal Investigator.